Dynavax Technologies

Ebitda Alterar Data
AbbVie USD 4.49B 2.26B 2024-03
Adma Biologics USD 24.28M 7.94M 2024-03
Amgen USD 2.16B 1.5B 2024-03
AstraZeneca USD 4.47B 1.67B 2024-03
Biogen USD 681.5M 29.4M 2024-03
BioMarin Pharmaceutical USD 136.44M 81.36M 2024-03
Bristol-Myers Squibb USD -8559000000 13.45B 2024-03
Dynavax Technologies USD -8140000 2.25M 2024-03
Gilead Sciences USD -3542000000 6.27B 2024-03
Glaxosmithkline GBP 2.07B 317M 2024-03
Merck USD 6.96B 557M 2024-03
Neurocrine Biosciences USD 41.8M 104.9M 2024-03
Novartis USD 4.66B 20M 2024-03
Pfizer USD 5.95B 4.81B 2024-03
Regeneron Pharmaceuticals USD 830.9M 485.5M 2024-03
Roche Holding CHF 12.35B 1.92B 2023-06
Sarepta Therapeutics USD 54.36M 64.27M 2024-03
TG Therapeutics USD -8308000 123.16M 2024-03
Vertex Pharmaceuticals USD 1.34B 262.8M 2024-03



Dynavax Technologies - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.